Clinical Trial Update: High Density Lipoprotein Turnover [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on high density lipoprotein turnover in obesity. The study has been terminated and the sponsor is Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Sanofi | Conditions: Obesity | Phase 3 | Status: TERMINATED